Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer in Japanese patients: a randomized controlled phase III trial

Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer in Japanese patients: a randomized controlled phase III trial - Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer: a randomized controlled phase III trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030582

Enrollment

160

Registered

2017-12-26

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

low-molecular-weight heparin after surgery no treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients who undergo surgery for colorectal cancer 2) age of 20 or older 3) presence of informed consent

Exclusion criteria

Exclusion criteria: 1) absence of informed consent 2) patients who doctors find unsuited 3) patients with bleeding after surgery 4) patients with preoperative anticoagulant therapy 5) patients with allergy for heparin 6) patients with acute bacteria endocarditis 7) severe renal dysfunction (Ccr<30ml/min) 8) patients with deep venous thrombosis at preoperative ultrasonography

Design outcomes

Primary

Measure	Time frame
The efficacy of low-molecular-weight heparin to prevent deep venous thrombosis after surgery for colorectal cancer	—

Countries

Japan

Contacts

Public ContactHirotoshi Kobayashi

Tokyo Metropolitan Hiroo Hospital Department of Surgery

hkoba@med.teikyo-u.ac.jp03-3444-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026